SCHEMBL1660050

SCHEMBL1660050

CC(C)c1cccc(Oc2nc(C(=O)O)co2)c1.CS(=O)(=O)c1c(F)cc(CNN)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KLKB1 P03952 1/20 0.39
PLG P00747 2/20 0.36
PLAU P00749 2/20 0.36
KCNQ3 O43525 1/20 0.34
KCNQ2 O43526 1/20 0.34
KCNQ4 P56696 1/20 0.34
KCNQ5 Q9NR82 1/20 0.34
CASP1 P29466 1/20 0.33
FFAR1 O14842 1/20 0.33
PFKFB3 Q16875 1/20 0.32
CA2 P00918 2/20 0.32
CA1 P00915 1/20 0.32
P2RX3 P56373 1/20 0.32
RORC P51449 1/20 0.32
GHSR Q92847 1/20 0.31
F3 P13726 2/20 0.30
PTGS1 P23219 1/20 0.30
F10 P00742 1/20 0.30
F7 P08709 1/20 0.30
F2 P00734 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660196 0.80 PTGS1 (0.45) KLKB1PLGPLAUCASP1PFKFB3
SCHEMBL12604678 0.79 KLKB1 (0.51) KLKB1PLGPLAURORCSMN1; SMN2
SCHEMBL1988531 0.79 KLKB1 (0.43) KLKB1SMN1; SMN2
SCHEMBL12563269 0.78 KLKB1 (0.49) KLKB1PLGPLAUFFAR1RORC
SCHEMBL1661398 0.73 KLKB1 (0.39) KLKB1CA2CA1SMN1; SMN2
SCHEMBL2878994 0.71 PTGS1 (0.40) KLKB1FFAR1PFKFB3P2RX3PTGS1
SCHEMBL12603590 0.71 KCNQ3 (0.41) KLKB1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL1986290 0.71 KCNQ3 (0.41) KLKB1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL12563259 0.69 KLKB1 (0.40) KLKB1KCNQ3KCNQ2KCNQ4KCNQ5
SCHEMBL2880398 0.69 MCL1 (0.46) KLKB1PTGS1F10F2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME Amorepacific Corporation (KR) 2011-04-13 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed